Long term (current) drug therapy - Z79

This notation helps users understand the scope of a code Z79 category and provides additional information about the conditions or terms that fall under that category.

Category Includes:

long term (current) drug use for prophylactic purposes

Excludes2: This note means that the conditions described by two codes are not usually associated with each other but can sometimes occur together.

Type 2 Excludes:

drug abuse and dependence (F11-F19)
drug use complicating pregnancy, childbirth, and the puerperium (O99.32-)

Code Also: It indicates that an additional code should be used alongside the primary code to capture related factors or associated conditions.

Category codeAlso:

any therapeutic drug level monitoring (Z51.81)

These ranges represents subcategories of Long term (current) drug therapy. The "Z79" signifies that these are the diseases within this broad category.

Codes:

Z79.0 - Long term (current) use of anticoagulants and antithrombotics/antiplatelets
Z79.01 - Long term (current) use of anticoagulants
Z79.02 - Long term (current) use of antithrombotics/antiplatelets
Z79.1 - Long term (current) use of non-steroidal anti-inflammatories (NSAID)
Z79.2 - Long term (current) use of antibiotics
Z79.3 - Long term (current) use of hormonal contraceptives
Z79.4 - Long term (current) use of insulin
Z79.5 - Long term (current) use of steroids
Z79.51 - Long term (current) use of inhaled steroids
Z79.52 - Long term (current) use of systemic steroids
Z79.6 - Long term (current) use of immunomodulators and immunosuppressants
Z79.60 - Long term (current) use of unspecified immunomodulators and immunosuppressants
Z79.61 - Long term (current) use of immunomodulator
Z79.62 - Long term (current) use of immunosuppressant
Z79.620 - Long term (current) use of immunosuppressive biologic
Z79.621 - Long term (current) use of calcineurin inhibitor
Z79.622 - Long term (current) use of Janus kinase inhibitor
Z79.623 - Long term (current) use of mammalian target of rapamycin (mTOR) inhibitor
Z79.624 - Long term (current) use of inhibitors of nucleotide synthesis
Z79.63 - Long term (current) use of chemotherapeutic agent
Z79.630 - Long term (current) use of alkylating agent
Z79.631 - Long term (current) use of antimetabolite agent
Z79.632 - Long term (current) use of antitumor antibiotic
Z79.633 - Long term (current) use of mitotic inhibitor
Z79.634 - Long term (current) use of topoisomerase inhibitor
Z79.64 - Long term (current) use of myelosuppressive agent
Z79.69 - Long term (current) use of other immunomodulators and immunosuppressants
Z79.8 - Other long term (current) drug therapy
Z79.81 - Long term (current) use of agents affecting estrogen receptors and estrogen levels
Z79.810 - Long term (current) use of selective estrogen receptor modulators (SERMs)
Z79.811 - Long term (current) use of aromatase inhibitors
Z79.818 - Long term (current) use of other agents affecting estrogen receptors and estrogen levels
Z79.82 - Long term (current) use of aspirin
Z79.83 - Long term (current) use of bisphosphonates
Z79.84 - Long term (current) use of oral hypoglycemic drugs
Z79.85 - Long-term (current) use of injectable non-insulin antidiabetic drugs
Z79.89 - Other long term (current) drug therapy
Z79.890 - Hormone replacement therapy
Z79.891 - Long term (current) use of opiate analgesic
Z79.899 - Other long term (current) drug therapy